Fosun International’s Verrica Pharmaceuticals VRCA Stock Holding History

Fosun International’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,901	Closed	-$355K	–	74
2022 Q4	$355K	Sell	12,901 -15,340	-54%	-$409K	0.03%	58
2022 Q3	$825K	Hold	28,241	–	–	0.09%	54
2022 Q2	$543K	Hold	28,241	–	–	0.08%	61
2022 Q1	$2.29M	Hold	28,241	–	–	0.2%	82
2021 Q4	$2.59M	Hold	28,241	–	–	0.15%	99
2021 Q3	$3.53M	Hold	28,241	–	–	0.18%	86
2021 Q2	$3.19M	Hold	28,241	–	–	0.19%	78
2021 Q1	$4.28M	Sell	28,241 -4,165	-13%	-$576K	0.34%	52
2020 Q4	$3.73M	Hold	32,406	–	–	0.24%	58
2020 Q3	$2.51M	Hold	32,406	–	–	0.22%	61
2020 Q2	$3.57M	Hold	32,406	–	–	0.34%	39
2020 Q1	$3.54M	Sell	32,406 -8,881	-22%	-$1.17M	0.34%	35
2019 Q4	$6.56M	Sell	41,287 -37,854	-48%	-$5.59M	0.55%	27
2019 Q3	$11.7M	Sell	79,141 -287	-0.4%	-$32K	1.29%	15
2019 Q2	$9.23M	Hold	79,428	–	–	0.61%	26
2019 Q1	$8.59M	Hold	79,428	–	–	0.55%	27
2018 Q4	$6.47M	Hold	79,428	–	–	0.39%	35
2018 Q3	$12.9M	Sell	79,428 -172	-0.2%	-$29.4K	0.62%	25
2018 Q2	$15.7M	Buy	+79,600	New	+$15.6M	0.8%	31

Other funds holding VRCA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Fosun International's VRCA Position: Q1 2023 in Review

Fosun International sold out of Verrica Pharmaceuticals (VRCA) in Q1 2023, closing a stake of 12,901 shares — an estimated $355K sold.

Fosun International first reported a position in VRCA in Q2 2018 and held it in 19 quarters. The position peaked at $15.7M in Q2 2018. 59 funds tracked by Wall St. Rank hold VRCA as of Q1 2023.

Fosun International reported no remaining Verrica Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Fosun International sold 12,901 Verrica Pharmaceuticals shares in Q1 2023, an estimated $355K.
Fosun International first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 19 quarters.
Fosun International's Verrica Pharmaceuticals position peaked at $15.7M in Q2 2018.
59 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2023.

Based on Fosun International's 13F filing for Q1 2023, filed 28 Apr 2023.